On 14th September 2026, Stockholm-based Tandem Health announced a $100 million (€86.5 million) Series B led by the Scaleup Europe Fund, the €5 billion vehicle managed by EQT and seeded by the European Commission, Novo Holdings, CriteriaCaixa and Santander. Existing backers Kinnevik, Northzone, Amino Collective and Visionaries all followed on. The round takes Tandem's total funding to roughly $160 million, barely fifteen months after its $50 million Series A and makes it the b